Actos® Drug Injury

Settlements Moving Forward in Actos® Bladder Cancer Lawsuits

by | October 19th, 2015

The diabetes drug, Actos®, has been linked to the development of bladder cancer in some patients. Many victims are seeking compensation for their losses with lawsuits against the maker of the drug. Now, many of those cases are beginning to come to a close.

In April, Takeda Pharmaceutical, Inc. offered more than $2 billion to settle a majority of the Actos bladder cancer lawsuits. It didn’t seem as though the deal would be closed in August, considering only 75 percent of the victims had agreed to the terms of the settlement. However, the company announced last month that they had reached settlements with 96 percent of the drug’s victims for an estimated $2.4 billion. This laid to rest seven of the nine remaining lawsuits the company is facing in connection with Actos bladder cancer cases.

Now, it seems as though another of those cases has been settled as well. Fierce Pharma reports a case involving to Nevada patients who developed bladder cancer after using Actos® has been settled. The terms of the agreement were not disclosed.

At Lowell Stanley Injury Lawyers, we are aware of the struggles many Actos bladder cancer victims face along their road to recovery. That’s why our drug injury lawyers are hopeful the settlements reached in these cases brings a sense of closure to those whose lives were affected by the dangers of the drug.

$2.4 Billion Settlement Offered in Actos® Drug Injury Lawsuit

by | May 12th, 2015

Studies show taking the drug Actos® to treat Diabetes can increase a patient’s chances of developing bladder cancer. Unfortunately, these findings were not released until after the medication was released to consumers. The discovery of these results prompted thousands of patients who were harmed by taking Actos to file lawsuits against the manufacturer of the drug, Takeda Pharmaceuticals. Now, our Actos® drug injury lawyers at Lowell Stanley Injury Lawyers explain a settlement has been offered by Takeda to those who have filed the lawsuits.

Takeda has offered $2.4 billion to settle roughly 9,000 pending lawsuits filed by patients who developed bladder cancer after taking Actos. According to an article from The Wall Street Journal, each claimant would receive around $267,000 if the terms that have been outlined are agreed to by 95 percent of the plaintiffs.

The deadline for plaintiffs to submit the documentation of their claim for approval as part of the settlement is in July and payments are expected to be made within a year of the settlement becoming finalized. This means there’s still time to get the compensation you deserve if you developed bladder cancer as a result of taking Actos.

At Lowell Stanley Injury Lawyers, our legal staff understands the hardships one can face as a result of being harmed by a prescribed medication. That’s why our Norfolk drug injury lawyers are hopeful this settlement can bring peace and closure to each of the victims who were harmed as a result of using Actos.